Sandoz Tells FDA Unique Biosimilar Names OK… Sometimes

If biosimilar sponsor doesn’t want brand name, nonproprietary name should have suffix, Sandoz says in update to its citizen petition.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America